20/20 Biolabs

AIDXNasdaq United States Health Care Precision Instruments

Market cap

$5.576 M

$0.46 +0.71%

Close of 7 Aug 2026

Revenue

$2.05M

#3432 by revenue

Earnings

-$3.74M

Loss-making

Shares outstanding

10,611,528

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Precision Instruments — ranked by market cap

All 3 →

#1UL SolutionsULS$15.8B
#2NeogenomicsNEO$2.13B
#320/20 BiolabsAIDX$5.58M

Where these numbers come from

Share counts and financials for 20/20 Biolabs are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.